COVID-19 Pandemic: MDS Statement, References and Resources

MDS Resources

MDS Statement Regarding COVID-19
MDS Telemedicine Guide
MDS Telemedicine Webinar
MDS Health Professionals (Non-Physician) SIG - Global Resources

COVID-19 Viewpoint and Joint Editorial
MDJ MDCP
Viewpoint Viewpoint
Joint Editorial Joint Editorial

Additional Articles on COVID-19 and Movement Disorders in MDS Journals

Parkinson's disease and COVID-19: Perceptions and implications in patients and caregivers.
Prasad S, Holla VV, Neeraja K, Surisetti BK, Kamble N, Yadav R, Pal PK.
Mov Disord. 2020 Apr 17

Outcome of Parkinson's Disease patients affected by COVID-19.
Antonini A, Leta V, Teo J, Chaudhuri KR.
Mov Disord. 2020 Apr 29.

Phenomenology and outcomes of in-patients with Parkinson's disease during COVID-19 pandemic.

Kobylecki C, Jones T, Lim CK, Miller C, Thomson AM.Kobylecki C, et al. Mov Disord. 2020 Jun 24:10.1002/mds.28205.

The Possible Protective Role of α-Synuclein Against Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Patients with Parkinson's Disease.

Ait Wahmane S, Achbani A, Ouhaz Z, Elatiqi M, Belmouden A, Nejmeddine M.Ait Wahmane S, et al. Mov Disord. 2020 Jun 9:10.1002/mds.28185.

COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.

Fasano A, Cereda E, Barichella M, Cassani E, Ferri V, Zecchinelli AL, Pezzoli G.Fasano A, et al. Mov Disord. 2020 Jul;35(7):1089-1093.

Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study.

Cilia R, Bonvegna S, Straccia G, Andreasi NG, Elia AE, Romito LM, Devigili G, Cereda E, Eleopra R.Cilia R, et al. Mov Disord. 2020 May 25:10.1002/mds.28170.

Virtual Parkinson's Disease Support Groups in the COVID-19 Era: Social Connection in the Time of Social Distancing.

Subramanian I.Subramanian I. Mov Disord Clin Pract. 2020 Jul 10;7(6):739-740


Selected Articles from Other Journals

Recommendations for Deep Brain Stimulation Device Management During a Pandemic.
Miocinovic S, Ostrem JL, Okun MS, Bullinger KL, Riva-Posse P, Gross RE, Buetefisch CM.
J Parkinsons Dis. 2020 Apr 24. doi: 10.3233/JPD-202072

The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities.
Helmich RC, Bloem BR.
J Parkinsons Dis. 2020;10(2):351-354

Remote Administration of the MDS-UPDRS in the Time of COVID-19 and Beyond.

Schneider RB, Myers TL, Tarolli CG, Amodeo K, Adams JL, Jensen-Roberts S, Dorsey ER.Schneider RB, et al. J Parkinsons Dis. 2020 Jul 15.

Telemedicine in Parkinson's Disease: How to Ensure Patient Needs and Continuity of Care at the Time of COVID-19 Pandemic.

Miele G, Straccia G, Moccia M, Leocani L, Tedeschi G, Bonavita S, Lavorgna L; Digital Technologies, Web and Social Media Study Group of the Italian Society of Neurology.Miele G, et al. Telemed J E Health. 2020 Jul 13

E-Rehabilitation: One solution for patients with Parkinson's disease in COVID-19 era.

Srivastav AK, Samuel AJ.Srivastav AK, et al. Parkinsonism Relat Disord. 2020 Jun 4:S1353-8020(20)30130-9.

Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson's Disease in Germany.

Zipprich HM, Teschner U, Witte OW, Schönenberg A, Prell T.Zipprich HM, et al. J Clin Med. 2020 May 29;9(6):E1643.

Functional movement disorders in a patient with COVID-19.

Piscitelli D, Perin C, Tremolizzo L, Peroni F, Cerri CG, Cornaggia CM.Piscitelli D, et al. Neurol Sci. 2020 Jul 14:1-2.

Promoting Physical Activity via Telehealth in People With Parkinson Disease: The Path Forward After the COVID-19 Pandemic?

Quinn L, Macpherson C, Long K, Shah H.

Recommendations for Deep Brain Stimulation Device Management During a Pandemic.

Miocinovic S, Ostrem JL, Okun MS, Bullinger KL, Riva-Posse P, Gross RE, Buetefisch CM.Miocinovic S, et al. J Parkinsons Dis. 2020;10(3):903-910.

The psychological impact of COVID-19 among a sample of Italian patients with functional neurological disorders: A preliminary study.

Nisticò V, Goeta D, Gambini O, Demartini B.

Neuropathologic features of four autopsied COVID-19 patients.

Kantonen J, Mahzabin S, Mäyränpää MI, Tynninen O, Paetau A, Andersson N, Sajantila A, Vapalahti O, Carpén O, Kekäläinen E, Kantele A, Myllykangas L.Kantonen J, et al. Brain Pathol. 2020 Aug 6:10.1111/bpa.12889.


COVID-19 and Movement Disorder Observations

Submission form

Repository 
(Members Only)


MDS Podcasts on COVID-19 and Movement Disorders

Movement Disorders in times of COVID-19: interview with the president on the MDS activities during the COVID crisis

Movement Disorders in times of COVID-19: Practicing medicine in time of pandemic and future of movement disorders medical practice

Movement Disorders in times of COVID-19


MDS-UPDRS Use in the COVID Era

Article by Christopher Goetz, Glenn Stebbins and Sheng Luo


Risk Assessment and Mitigation Strategies for Collection of Patient-Reported Outcome Data through Clinical Sites
Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice